Dysan Chao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dysan Chao has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Chien-Chin Lee
Epigenome Research Center, China Medical University Hospital, Taichung 40447, Taiwan
1 shared publication- Hsi-Yuan Huang
School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen 518172, China
1 shared publication - Jan-Gowth Chang
Computing Center for Precision Integration of Chinese and Western Genomic Medicines, Show Chwan Memorial Hospital, Changhua, Taiwan.
1 shared publication - Ju-Chen Yen
Center for Precision Medicine, China Medical University Hospital, Taichung 404332, Taiwan
1 shared publication - Ting-Yuan Liu
Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung 404327, Taiwan
1 shared publication - Ya-Sian Chang
Center for Precision Medicine, China Medical University Hospital, Taichung 40447, Taiwan
1 shared publication
Latest Publications
- Open Access
- 11 April 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (4) , 951
Mutation Analysis of Second Primary Tumors in Oral Cancer in Taiwanese Patients through Next-Generation Sequencing
Head and neck cancer has poor overall survival. Patients with head and neck cancer more frequently develop second primary tumors than do patients with other cancers, leading to a poor prognosis. In this study, we used next-generation sequencing to analyze and compare mutations between first tumors and second tumors in oral cancer. We retrieved tumor tissues collected from 13 patients who were diagnosed twice as having cancer. We used driver gene and trunk mutations to distinguish between recurrent cancer and primary cancer in oral cancer. We observed unique driver gene mutations in three patients with an initial clinical diagnosis of recurrent cancer; hence, we believe that the corresponding patients had primary cancer. Four patients with an initial clinical diagnosis of primary cancer were found to actually have recurrent cancer according to our results. Genetic testing can be used to enhance the accuracy of clinical diagnosis.
- 11 April 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (4) , 951
Open AccessMutation Analysis of Second Primary Tumors in Oral Cancer in Taiwanese Patients through Next-Generation Sequencing
Head and neck cancer has poor overall survival. Patients with head and neck cancer more frequently develop second primary tumors than do patients with other cancers, leading to a poor prognosis. In this study, we used next-generation sequencing to analyze and compare mutations between first tumors and second tumors in oral cancer. We retrieved tumor tissues collected from 13 patients who were diagnosed twice as having cancer. We used driver gene and trunk mutations to distinguish between recurrent cancer and primary cancer in oral cancer. We observed unique driver gene mutations in three patients with an initial clinical diagnosis of recurrent cancer; hence, we believe that the corresponding patients had primary cancer. Four patients with an initial clinical diagnosis of primary cancer were found to actually have recurrent cancer according to our results. Genetic testing can be used to enhance the accuracy of clinical diagnosis.